Fig. 5

Effects of Sfpr4 KO and zoledronic acid (ZA) treatment on trabecular bone parameters. Mice were dosed intraperitoneally with saline or zoledronic acid (20 μg·kg−1) at 8 weeks of age. Male and female mice were examined at 68 and 24 weeks of age, respectively. Data are means ± SEM for 5 to 8 mice per group with statistical analysis by two-factor ANOVA